Teva Pharmaceutical Industries Ltd (TEVA)
NYSE
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current TEVA market cap is 19.37B. The company's latest EPS is USD -0.4935 and P/E is -30.94.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.66B | 3.88B | 3.85B | 4.46B | 3.82B |
| Operating Income | 2M | -646M | 355M | 697M | -216M |
| Net Income | -205M | -863M | 80M | 429M | -139M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 16.89B | 16.66B | 15.88B | 14.93B | 15.85B |
| Operating Income | -443M | -3.58B | 1.71B | -2.12B | 408M |
| Net Income | -999M | -3.99B | 417M | -2.35B | -559M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 43.46B | 43.1B | 42.09B | 43.48B | 42.77B |
| Total Liabilities | 34.84B | 35.39B | 34.58B | 35.35B | 35.23B |
| Total Equity | 8.61B | 7.71B | 7.51B | 8.13B | 7.54B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 57.47B | 50.64B | 47.67B | 44.01B | 43.48B |
| Total Liabilities | 42.41B | 39.58B | 36.42B | 35.32B | 35.35B |
| Total Equity | 15.06B | 11.06B | 11.24B | 8.69B | 8.13B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -145M | 179M | 184M | 1.37B | -124M |
| Investing | 181M | 483M | 667M | 968M | 144M |
| Financing | -706M | -761M | -1.34B | -1.91B | -152M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 748M | 1.22B | 798M | 1.59B | 1.37B |
| Investing | 1.36B | 863M | 1.52B | 656M | 968M |
| Financing | -1.93B | -1.89B | -2.17B | -1.49B | -1.91B |
| Market Cap | 19.37B |
| Price to Earnings Ratio | -30.94 |
| Price to Sales Ratio | 1.09 |
| Price to Cash Ratio | 5.36 |
| Price to Book Ratio | 2.13 |
| Dividend Yield | - |
| Shares Outstanding | 1.13B |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.26 (1.52%) |
| Company Name | Teva Pharmaceutical Industries Ltd |
| Address |
124 dvora hanevi’a st tel aviv, center 6944020 |
| Website | https://www.tevapharm.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
